Difference between revisions of "Angiocidin"
m (Created page with "{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | Substrate pepti...") |
m |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 6: | Line 6: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | | + | | 26S proteasome non-ATPase regulatory subunit 4 |
|- | |- | ||
| Determination type | | Determination type | ||
| Line 15: | Line 15: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | Extracellular matrix | + | | Cytosol/Extracellular matrix |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| Line 30: | Line 30: | ||
|- | |- | ||
| Structure | | Structure | ||
| − | | [http://www.rcsb.org/pdb/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore.do?structureId=2kdf 2KDF] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| Line 42: | Line 42: | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | Cross-linked angiocidin disrupts the tumor ECM making it less permissive for tumor growth. |
| + | Angiocidin inhibits tTgase-dependent incorporation of fibronectin into the ECM. | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:23, 10 March 2015
| Angiocidin | |
|---|---|
| Substrate peptide name | Angiocidin |
| Synonyms | 26S proteasome non-ATPase regulatory subunit 4 |
| Determination type | In situ |
| Source | Homo sapiens (HUVEC) |
| Subcellular localization | Cytosol/Extracellular matrix |
| Swissprot ID | P55036 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | - |
| Substrate sequence | Not determined yet |
| Structure | 2KDF |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:19931242 |
| Notes | Cross-linked angiocidin disrupts the tumor ECM making it less permissive for tumor growth.
Angiocidin inhibits tTgase-dependent incorporation of fibronectin into the ECM. |
